ARCHIVED - Recommendations on a Human Papillomavirus Immunization Program

 

Appendix 5

Summary of CIC Recommendations


Routine immunization

To decrease the morbidity and mortality associated with cervical cancer, its precursors and other HPV-related cancers in women in Canada, the CIC recommends school-based HPV vaccination of one female cohort to be implemented in all Canadian provinces and territories.

  1. To immunize 80% of school-aged girls in either grade 4, 5, 6, 7 or 8 with the required doses of the HPV vaccine within 2 years of program introduction.
  2. To immunize 90% of school-aged girls in either grade 4, 5, 6, 7 or 8 with the required doses of the HPV vaccine within 5 years of program introduction.

Particular efforts should be undertaken to achieve high vaccine coverage for routine programs in hard-to-reach and high-risk populations. Catch-up strategies could be extended to these populations.


Catch-up immunization

For jurisdictions that wish to and are able to consider catch-up programs could proceed with the inclusion of additional female cohorts. Particular efforts should be undertaken to achieve high vaccine coverage for routine programs in hard-to-reach and high-risk populations. Catch-up strategies could also be extended to these populations.


Immunization schedules

Following the manufacturers' indications for the quadrivalent HPV vaccine, NACI recommends a three-dose schedule (0, 2 and 6 months),(2).


Impact of vaccination on cervical cancer screening

The introduction of vaccination is expected to have a major impact ultimately on screening recommendations, and the two activities must now be planned simultaneously. An immunization program should constitute part of a comprehensive cervical cancer prevention program.


Program evaluation

To develop a detailed evaluation plan that would include:

  • Vaccination coverage;
  • Incidence and prevalence of HPV-associated diseases and cervical cancer;
  • Efficacy and duration of protection by the vaccine;
  • Psychosocial impact of vaccination; and
  • Optimal cervical cancer screening approaches.

Report a problem or mistake on this page
Please select all that apply:

Privacy statement

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: